Form CS 341327-A CS 341327-A FluSurv-NET Laboratory Survey 2023–2024 Season

Testing Facility Name:

Testing Facility ID (FluSurv-NET use only):

Name of person responding to questions for laboratory:

Date:

Title:
Form Approved
OMB No. 0920-0978

FluSurv-NET Laboratory Survey 2023–2024 Season
Survey Introduction
Administer this survey to labs that serve FluSurv-NET hospitals. The questions in this survey refer to diagnostic testing ordered by healthcare
providers for routine clinical care of hospitalized and emergency department (ED) patients only. All questions relate to testing performed on-site
within the lab facility unless otherwise specified. If a FluSurv-NET hospital lab sends specimens to one or more labs (other than commercial or state
public health labs) for clinical influenza, please have each lab complete this survey.
• Do NOT administer this survey to commercial labs or to state public health labs
• Do NOT administer this survey to labs that are not affiliated with FluSurv-NET hospitals
• Do NOT include information on testing for the purposes of EIP influenza
• Do NOT include information on testing for outpatients
This survey should take 5-10 minutes to complete. Thank you for your time!

Question
1. What is the role of the person completing this survey?
Laboratory staff at testing facility

FluSurv-NET staff

2. Please select the choice which best describes the laboratory type: (select one)
Hospital (private/public/community) laboratory

County public health laboratory

Federal government (military, IHS, Veteran’s Affairs) hospital laboratory

Other (specify):

University/medical school hospital laboratory
3. Does the laboratory currently (or plan to in the next year) send out specimens to be tested with the Karius Test?
Yes

No

Unknown

Influenza
4. Does the laboratory perform diagnostic testing for influenza on-site?
Yes  Answer question 5

No  Skip to question 9

5. Does the laboratory perform rapid influenza antigen diagnostic test (rapid test, RIDT)?
Yes, pediatric patients only  Answer question 5a
Yes, adult patients only  Answer question 5a

No, we confirm RIDT tests performed elsewhere in the hospital
(such as ED)  Skip to question 6

Yes, pediatric and adult patients  Answer question 5a

No  Skip to question 6

5a. Select the kit name(s) (manufacturer) for the rapid influenza antigen diagnostic test(s) performed or planned to be used at the laboratory:
(Check all that apply)
(https://www.cdc.gov/flu/professionals/diagnosis/table-ridt.html)
Acucy Influenza A&B Test (Sekisui Diagnostics, LLC)

CareStart Flu A&B Plus, (Access Bio, Inc.)

BD Veritor System for Rapid Detection of Flu A+B (CLIA-waived),
(Becton Dickinson & Co.)

OSOM Ultra Plus Flu A&B Test (Sekisui Diagnostics, LLC)

BD Veritor™ System for Rapid Detection of Flu A+B (Moderately Complex),
(Becton Dickinson & Co.)

SARS-CoV-2 & Flu A/B Rapid Antigen Test (Roche)

BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B (Becton
Dickinson & Co.)

Sofia® Analyzer and Influenza A+B FIA (Quidel Corp.)

™

QuickVue® Influenza A+B Test (Quidel Corp.)

Binax NOW® Influenza A&B Card 2 (Abbott)

Sofia® Analyzer and Influenza A+B FIA (CLIA-waived) (Quidel Corp.)
XPECT™ Influenza A/B (Remel Inc./Thermo Fisher Scientific)
Other, specify:

 ioSign® Flu A+B or LifeSign LLC Status Flu A & B (Princeton
B
BioMeditech Corp.)

Public reporting burden of this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering
and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of
information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for
reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30329; ATTN: PRA (0920-0978).

CS 341327-A

7/31/2023

Page 1 of 3

6. Does the laboratory perform molecular assays (including rapid molecular, RT-PCR, RVPs) for influenza?
Yes  Answer questions 6a-6c

No  Skip to question 7

6a. Select kit name(s) (manufacturer) for all molecular assays performed or planned to be used at the laboratory: (Check all that apply)
(https://www.cdc.gov/flu/professionals/diagnosis/table-nucleic-acid-detection.html) Multiplex Assays Authorized for Simultaneous Detection
of Influenza Viruses and SARS-CoV-2 by FDA: (https://www.cdc.gov/flu/professionals/diagnosis/table-flu-covid19-detection.html)
Accula Flu A/Flu B (Mesa Biotech, Inc.)†
Alinity M Resp-4 Plex Assay (Abbott)‡
Aptima SARS-CoV-2/Flu/A/B (Hologic)‡
ARIES® Flu A/B & RSV Assay, (Luminex)

FluChip-8G Influenza A+B Assay, (InDevR)*
ID Now™ Influenza A&B (CLIA Waived), (Abbott)†
Lyra Influenza A+B Assay, (Quidel)
NeuMoDX influenza A/b, RSV, and SARS-Cov-2 Vantage Assay (Qiagen)‡
Nx-TAG Respiratory Pathogen Panel, (Luminex Molecular Diagnostics Inc)*

ARIES Flu A/B & RSV+SARS‑CoV‑2 Assay
®

‡

BioCode® CoV-2 Flu Plus Assay (Applied BioCode Inc)‡
BioCode Respiratory Pathogen Panel, (Applied BioCode Inc)*
BioFire Pneumonia Panel (Biomerieux)
BioFire Pneumonia plus Panel (Biomerieux)
BioFire Respiratory Panel 2.1 (RP2.1) (Biomerieux)*‡
BioFire Respiratory Panel 2.1-EZ (RP2.1-EZ) (Biomerieux)*‡
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel
(Influenza B Lineage Genotyping Kit), (CDC Influenza Division)
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel
(Influenza A Subtyping Kit), (CDC Influenza Division)
CDC Influenza A/H5 (Asian Lineage) Virus Real-Time RT-PCR Primer
and Probe Set, (CDC Influenza Division)
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel
(Influenza A/B Typing Kit), (CDC Influenza Division)
CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
(CDC Influenza Division)‡
Cobas Liat Influenza A/B, (Roche Diagnostics)†
Cobas Liat Influenza A/B & RSV, (Roche Diagnostics)†
Cobas SARS-CoV-2 & Influenza A/B (Roche Diagnostics)‡
Cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test, (Roche
Diagnostics)
ePlex Respiratory Pathogen Panel (GenMark Diagnostics)*†‡
ePlex Respiratory Pathogen Panel 2, (Genmark Diagnostics)*‡

Nx-TAG® Respiratory Pathogen Panel + SARS‑CoV‑2 (Luminex Molecular
Diagnostics Inc)*‡
Panther Fusion® Flu A/B RSV, (Assay Hologic)
Panther Fusion SARS-CoV-2/Flu A/B/RSV (Hologic)‡
QIAstat-Dx Respiratory SARS-CoV-2 Panel (QIAGEN)*‡
Quest Diagnostics RC COVID-19 +Flu RT-PCR, (Quest Diagnostics)‡
RealStar Influenza Screen & Type RT-PCR
Simplexa™ Flu A/B & RSV, (Focus Diagnostics, 3M)
Simplexa™ Flu A/B & RSV Direct, (Focus Diagnostics, 3M)
Simplexa™ Influenza A H1N1 (2009), (Focus Diagnostics, 3M)
Simplexa™ Flu A/B & RSV Gen II (Diasorin)‡
Sofia 2 Flu + SARS Antigen FIA, (Quidel) †‡
Solana Influenza A+B Assay, (Quidel)
Solana Respiratory Viral Panel, (Quidel)
Verigene® Respiratory Pathogen Nucleic Acid Test (RP Flex), (Luminex)*
Xpert Xpress COV-2/Flu/RSV plus†‡
Xpert Xpress Flu/RSV Assay, (Cepheid) †
In-house developed PCR assay
Other, specify:
= Rapid Molecular

†

*= can detect subtype

‡=Multiplex for influenza/SARS-CoV-2

6b. If more than one kit is selected above, please select the one kit that is (or will be) used most frequently for molecular assay at the laboratory
during the current influenza season:
Accula Flu A/Flu B (Mesa Biotech, Inc.)†
Alinity M Resp-4 Plex Assay (Abbott)‡
Aptima SARS-CoV-2/Flu/A/B (Hologic)‡
ARIES® Flu A/B & RSV Assay, (Luminex)

FluChip-8G Influenza A+B Assay, (InDevR)*
ID Now™ Influenza A&B (CLIA Waived), (Abbott)†
Lyra Influenza A+B Assay, (Quidel)
NeuMoDX influenza A/b, RSV, and SARS-Cov-2 Vantage Assay (Qiagen)‡
Nx-TAG Respiratory Pathogen Panel, (Luminex Molecular Diagnostics Inc)*

ARIES Flu A/B & RSV+SARS‑CoV‑2 Assay
®

‡

BioCode® CoV-2 Flu Plus Assay (Applied BioCode Inc)‡
BioCode Respiratory Pathogen Panel, (Applied BioCode Inc)*
BioFire Pneumonia Panel (Biomerieux)
BioFire Pneumonia plus Panel (Biomerieux)
BioFire Respiratory Panel 2.1 (RP2.1) (Biomerieux)*‡
BioFire Respiratory Panel 2.1-EZ (RP2.1-EZ) (Biomerieux)*‡
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel
(Influenza B Lineage Genotyping Kit), (CDC Influenza Division)
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel
(Influenza A Subtyping Kit), (CDC Influenza Division)
CDC Influenza A/H5 (Asian Lineage) Virus Real-Time RT-PCR Primer
and Probe Set, (CDC Influenza Division)
CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel
(Influenza A/B Typing Kit), (CDC Influenza Division)
CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
(CDC Influenza Division)‡
Cobas Liat Influenza A/B, (Roche Diagnostics)†
Cobas Liat Influenza A/B & RSV, (Roche Diagnostics)†
Cobas SARS-CoV-2 & Influenza A/B (Roche Diagnostics)‡
Cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test, (Roche
Diagnostics)
ePlex Respiratory Pathogen Panel (GenMark Diagnostics)*†‡
ePlex Respiratory Pathogen Panel 2, (Genmark Diagnostics)*‡
FluSurv-NET Laboratory Survey 2023–2024 Season

Nx-TAG® Respiratory Pathogen Panel + SARS‑CoV‑2 (Luminex Molecular
Diagnostics Inc)*‡
Panther Fusion® Flu A/B RSV, (Assay Hologic)
Panther Fusion SARS-CoV-2/Flu A/B/RSV (Hologic)‡
QIAstat-Dx Respiratory SARS-CoV-2 Panel (QIAGEN)*‡
Quest Diagnostics RC COVID-19 +Flu RT-PCR, (Quest Diagnostics)‡
RealStar Influenza Screen & Type RT-PCR
Simplexa™ Flu A/B & RSV, (Focus Diagnostics, 3M)
Simplexa™ Flu A/B & RSV Direct, (Focus Diagnostics, 3M)
Simplexa™ Influenza A H1N1 (2009), (Focus Diagnostics, 3M)
Simplexa™ Flu A/B & RSV Gen II (Diasorin)‡
Sofia 2 Flu + SARS Antigen FIA, (Quidel) †‡
Solana Influenza A+B Assay, (Quidel)
Solana Respiratory Viral Panel, (Quidel)
Verigene® Respiratory Pathogen Nucleic Acid Test (RP Flex), (Luminex)*
Xpert Xpress COV-2/Flu/RSV plus†‡
Xpert Xpress Flu/RSV Assay, (Cepheid) †
In-house developed PCR assay
Other, specify:
= Rapid Molecular

†

Page 2 of 3

*= can detect subtype

‡=Multiplex for influenza/SARS-CoV-2

6c. Does the laboratory perform influenza A subtyping?
Yes

No

7a. Which influenza test method does the laboratory perform most frequently for hospitalized pediatric patients (aged 0-17 years)? (Select one)
Rapid influenza antigen diagnostic test (rapid test, RIDT)

Standard Molecular assay (e.g. RT-PCR, NAAT) – singleplex (influenza only)

Rapid Molecular assay – singleplex (influenza only)†

Standard Molecular assay (e.g. RT-PCR, NAAT) – dualplex/multiplex/
respiratory viral panel (RVP)

Rapid Molecular assay – dualplex/multiplex†

Not applicable (no pediatric testing)
=Rapid Molecular assays which provide results in <30 minutes, include, but are not limited to the following kits: IDNow™, Accula Flu A/Flu B,Cobas® Liat Influenza A/B Assay, Cobas®
Liat Influenza A/B & RSV Assay, Silaris Influenza A&B, Sofia 2 Flu + SARS Antigen FIA, Xpert Xpress

†

7b. Which influenza test method does the laboratory perform most frequently for hospitalized adult patients (aged ≥18 years)? (Select one)
Rapid influenza antigen diagnostic test (rapid test, RIDT)

Standard Molecular assay (e.g. RT-PCR, NAAT) – singleplex (influenza only)

Rapid Molecular assay – singleplex (influenza only)

Standard Molecular assay (e.g. RT-PCR, NAAT) – dualplex/multiplex/
respiratory viral panel (RVP)

†

Rapid Molecular assay – dualplex/multiplex†

Not applicable (no pediatric testing)
=Rapid Molecular assays which provide results in <30 minutes, include, but are not limited to the following kits: IDNow™, Accula Flu A/Flu B,Cobas® Liat Influenza A/B Assay, Cobas®
Liat Influenza A/B & RSV Assay, Silaris Influenza A&B, Sofia 2 Flu + SARS Antigen FIA, Xpert Xpress

†

8. Based on tests that were performed during the 2022-2023 influenza season, approximately what percent of the time are each of these test types
used to test for flu overall? (Answers should add to 100%)
% Other test type
% Rapid influenza antigen diagnostic test (rapid test, RIDT)
% Rapid Molecular assay – singleplex (influenza only)†
% Rapid Molecular assay (e.g. RT-PCR - dualplex/multiplex†
% Standard Molecular assay – singleplex (influenza only)
% Standard Molecular assay) – dualplex/multiplex/respiratory viral panel (RVP)
=Rapid Molecular assays which provide results in <30 minutes, include, but are not limited to the following kits: IDNow™, Accula Flu A/Flu B,Cobas® Liat Influenza A/B Assay, Cobas®
Liat Influenza A/B & RSV Assay, Silaris Influenza A&B, Sofia 2 Flu + SARS Antigen FIA, Xpert Xpress

†

9. Does the lab send specimens to other labs for clinical testing of influenza? (optional)
Yes  Answer question 9a

No  Skip to question 10

9a. Select all that apply: (optional)
Commercial lab(s): List names of all labs:
Public Health lab(s): List names of all labs:
Other lab(s): List names of all labs:
10. Laboratory comments:

FluSurv-NET site use only
11. List all in - catchment FluSurv-NET hospital IDs (hosp_TX) associated with this testing facility.
Hospital ID 1 (Required):

Hospital ID 6:

Hospital ID 2:

Hospital ID 7:

Hospital ID 3:

Hospital ID 8:

Hospital ID 4:

Hospital ID 9:

Hospital ID 5:

Hospital ID 10:

CS 341327-A

7/31/2023

Page 3 of 3

(Do not include names - CDC receives this info)